Skip to main content
. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072

Fig. 4.

Fig. 4

Rare HCV GT subtypes in DAA-naive vs. -experienced patients.

(A) Overall frequencies of rare GT subtypes in patients after first and second generation DAA failure compared to DAA-naive patients. (B) Distribution of rare HCV subtypes among DAA-failure patients, stratified for first and second generation DAAs. DAA, direct-acting antiviral; GT, genotype. Patients with rare GT6 subtypes and PrOD, GZR/EBR, LDV/SOF failure were partially misclassified as GT1 in commercial genotyping assays.